Slowing polycystic kidney disease by inhibition of HIF-1α-dependent- and calcium-mediated secretory signaling pathways (A02)
Slowing polycystic kidney disease by inhibition of HIF-1α-dependent- and calcium-mediated secretory signaling pathways (A02)
批准号:
415807670
负责人:
金额:
$0.0万
依托单位国家:
德国
项目类别:
Collaborative Research Centres
财政年份:
2019
资助国家:
德国
项目状态:
已结题
起止时间:
2018-12-31 至 2021-12-31
中文摘要
常染色体显性多囊肾病(ADPKD)的特征是由于液体分泌到囊肿腔内而导致囊肿持续生长。我们的初步工作表明,atp依赖性,Ca2+激活的Cl-分泌以及HIF-1α和ROS信号有助于这种液体运输。在这里,我们将测试是否可以通过药物抑制这些途径来减缓囊肿的进展。此外,我们将分析导致腔内ATP释放的机制及其对囊肿增大的影响。预期的结果将有助于了解ADPKD中囊肿持续扩张的潜在机制,并确定适用的药物靶点来抑制囊肿生长和保持肾功能。
英文摘要
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is characterized by continuous cyst growth due to fluid secretion into the cyst lumen. Our preliminary work indicates that ATP-dependent, Ca2+-activated Cl- secretion as well as HIF-1α and ROS signaling contribute to this fluid transport. Here, we will test if cyst progression can be slowed down by pharmacological inhibition of these pathways. In addition, we will analyze the mechanism leading to luminal ATP release and its effect on cyst enlargement. The expected results will help to understand the underlying mechanisms of continuous cyst expansion in ADPKD and to identify applicable drug targets to inhibit cyst growth and preserve renal function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
-
批准号:82370797
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陶弢
-
依托单位: